| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. | Oncotarget | 2012 | 1.11 |
| 2 | The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack. | Cancer Res | 2010 | 0.99 |
| 3 | Protein tyrosine nitration and thiol oxidation by peroxynitrite-strategies to prevent these oxidative modifications. | Int J Mol Sci | 2013 | 0.89 |
| 4 | Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia. | Adv Hematol | 2011 | 0.79 |
| 5 | Intrathecal saline infusion: an emergency procedure in a patient with spontaneous intracranial hypotension. | Neurocrit Care | 2013 | 0.75 |